What have we been up to?
From partnership and fundraising announcements to co-founders interviews and AI in pharma news, discover in this news section what we have been up to.
Interview with Dr. Julien Calderaro on AI and Cancer Research
Owkin publishes breakthrough research in Nature Medicine: Novel deep-learning approach for predicting and explaining the key prognostic factors in Mesothelioma
Owkin wins first “AI for Health” challenge from Île-de-France Region & Institut Gustave Roussy – French
Pharma groups combine to promote drug discovery with AI in Owkin led Mellody consortium
Owkin closes a new venture round led by F-Prime Capital and Eight Roads Ventures
Owkin appoints Dr. Bruno Strigini, former CEO of Novartis Oncology, as Chairman of the Board